Characterization of the steric defense of the HIV-1 gp41 N-trimer region.
about
Structural mechanism of trimeric HIV-1 envelope glycoprotein activationStructural Basis of HIV-1 Neutralization by Affinity Matured Fabs Directed against the Internal Trimeric Coiled-Coil of gp41Affinity maturation by targeted diversification of the CDR-H2 loop of a monoclonal Fab derived from a synthetic naïve human antibody library and directed against the internal trimeric coiled-coil of gp41 yields a set of Fabs with improved HIV-1 neutEarly steps of HIV-1 fusion define the sensitivity to inhibitory peptides that block 6-helix bundle formation.Affinity maturation and characterization of a human monoclonal antibody against HIV-1 gp41Long-lasting enfuvirtide carrier pentasaccharide conjugates with potent anti-human immunodeficiency virus type 1 activity.Antibody to gp41 MPER alters functional properties of HIV-1 Env without complete neutralizationSub-inhibitory concentrations of human α-defensin potentiate neutralizing antibodies against HIV-1 gp41 pre-hairpin intermediates in the presence of serum.Single-chain protein mimetics of the N-terminal heptad-repeat region of gp41 with potential as anti-HIV-1 drugs.Monoclonal antibody-based candidate therapeutics against HIV type 1.Receptor Activation of HIV-1 Env Leads to Asymmetric Exposure of the gp41 Trimer.Peptides in the treatment of AIDS.Amphipathic properties of HIV-1 gp41 fusion inhibitors.Human Immunodeficiency Virus and Simian Immunodeficiency Virus Maintain High Levels of Infectivity in the Complete Absence of Mucin-Type O-Glycosylation.Site-Specific Polymer Attachment to HR2 Peptide Fusion Inhibitors against HIV-1 Decreases Binding Association Rates and Dissociation Rates Rather Than Binding Affinity.The C34 Peptide Fusion Inhibitor Binds to the Six-Helix Bundle Core Domain of HIV-1 gp41 by Displacement of the C-Terminal Helical Repeat Region.Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin.Pharmacokinetic and Chemical Synthesis Optimization of a Potent d-Peptide HIV Entry Inhibitor Suitable for Extended-Release Delivery.A Novel gp41-Binding Adnectin with Potent Anti-HIV Activity Is Highly Synergistic when Linked to a CD4-Binding Adnectin.
P2860
Q21131394-24771168-F210-48F9-9C29-CC6E6C36E091Q27665960-8A38B4F2-60F5-4CE2-8724-B646C81E1D2EQ33495440-5208F760-537E-4C5A-AD7D-681AECAC462EQ33504556-13914140-5302-4942-8098-2A18EB0D6978Q33523258-3A016348-7A01-4281-8D3A-9C7DC926BB44Q33559031-7A67E9E2-37DA-4A9A-81BD-8EBAB7F395E1Q33946158-84B21315-10F5-4E88-8FEA-1BA7C4C92BE1Q34778515-5E0338C6-D5DE-4B23-845B-3D078A6254C0Q34793125-BBC67A7F-A3ED-4A7E-BFB4-477C0D92DF60Q35904501-D4CC863E-8948-471C-9842-CB1E5E28262AQ36228646-7D3EC38C-9837-466A-A724-28312A02642AQ37562113-20E28707-DD54-45B3-BA03-5C72443EF47AQ37951610-742E818B-2646-4C74-8818-81A314306D4BQ38659327-A5583CE2-D92A-4E47-B55C-EB8375516EE9Q38741307-6101619D-4EB1-4545-8F62-BC8D982CC05FQ40387378-2DAF85AB-7A1A-4E29-9FF7-DA880B38E8EBQ41041346-5032A9A9-0F0B-48D1-8AA8-E737E9565CE0Q50046992-A301F5B7-A1FE-439F-A050-0A62947ABAEEQ54216810-8FFC7A0F-0972-4BE3-B275-B067E308B6A2
P2860
Characterization of the steric defense of the HIV-1 gp41 N-trimer region.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Characterization of the steric defense of the HIV-1 gp41 N-trimer region.
@en
type
label
Characterization of the steric defense of the HIV-1 gp41 N-trimer region.
@en
prefLabel
Characterization of the steric defense of the HIV-1 gp41 N-trimer region.
@en
P2093
P2860
P356
P1433
P1476
Characterization of the steric defense of the HIV-1 gp41 N-trimer region.
@en
P2093
Brett D Welch
Debra M Eckert
Emily S Poff
Eunchai Kang
Michael S Kay
Sunghwan Kim
P2860
P304
P356
10.1110/PS.038273.108
P577
2008-09-18T00:00:00Z